Marpai (Marpai) Cash, Cash Equivalents, Marketable Securities : $0.85 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Marpai Cash, Cash Equivalents, Marketable Securities?

Marpai's quarterly cash, cash equivalents, marketable securities declined from Sep. 2023 ($3.02 Mil) to Dec. 2023 ($1.15 Mil) but then stayed the same from Dec. 2023 ($1.15 Mil) to Mar. 2024 ($0.85 Mil).

Marpai's annual cash, cash equivalents, marketable securities declined from Dec. 2021 ($19.18 Mil) to Dec. 2022 ($13.77 Mil) and declined from Dec. 2022 ($13.77 Mil) to Dec. 2023 ($1.15 Mil).

Marpai Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Marpai's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marpai Cash, Cash Equivalents, Marketable Securities Chart

Marpai Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash, Cash Equivalents, Marketable Securities

0.19

1.76

19.18

13.77

1.15

Marpai Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial											6.18	8.73	3.02	1.15	0.85

Marpai Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Marpai (NAS:MRAI) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Marpai Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Marpai's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Marpai (Marpai) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Marpai Inc (NAS:MRAI) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

PFHO UNH ELV CI CVS HUM CNC MOH SZSE:000503 ALHC BSP:ODPV3 OSCR CLOV BSP:QUAL3 BHG ROCO:6665 MIL:HI TSXV:NXG

Traded in Other Exchanges

N/A

Address

5701 East Hillsborough Avenue, Suite 1417, Tampa, FL, USA, 33610-5428

Website

https://www.marpaihealth.com

Marpai Inc operates as a health plan company. It uses A.I. to predict and help prevent costly events for its members, and in turn, lower its clients' health care costs. It offers a health plan services system that addresses the problems of healthcare past and enables companies to provide healthcare to employees. The company generates the majority of its revenue from the United States.

Executives

Yaron Eitan	director	65 CHALLENGER ROAD, RIDGEFIELD PARK NJ 07660
Damien Lamendola	director, 10 percent owner	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Edmundo Gonzalez	director, officer: CEO, Secretary and Director	C/O SELWAY CAPITAL ACQUISITION CORP., 74 GRAND AVENUE, 2ND FLOOR, ENGLEWOOD NJ 07631
Sagiv Shiv	director
Vincent Kane	director	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33131
Ronnie Brown	officer: Chief Operating Officer	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Mohsen Moazami	director	C/O ASTREA ACQUISITION CORP., 55 OCEAN LANE DRIVE, APT. 3021, KEY BISCAYNE FL 33149
Lutz Finger	officer: See Remarks	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610
Yoram Bibring	officer: Chief Financial Officer	C/O SELWAY ACQUISITION CORPORATION, 66 FORD ROAD, SUITE 230, DENVILLE NJ 07834
Jane Cavalier	director	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Diclaudio Colleen	director	456 SEATON STREET, LOS ANGELES CA 90013
Art Hoath	officer: Chief Revenue Officer	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Gonen Antebi	director	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Eli David	other: See footnote (1)	5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33131